School of Medicine
Showing 581-600 of 864 Results
-
Jackson Powell
MD Student, expected graduation Spring 2029
Ph.D. Student in Bioengineering, admitted Autumn 2026
MSTP StudentCurrent Research and Scholarly InterestsI am broadly interested in brain-computer interfaces. This includes reading neural activity through clinical means like intracranial EEG, or lab methods like Neuropixels. Similarly, I am interested in neuromodulation, such as deep brain stimulation for neurosurgical patients, or optogenetics for discovery.
-
Johnny G. Powell
MD Student with Scholarly Concentration in Community Health, expected graduation Spring 2028
MBA, expected graduation 2028BioJohnny Powell, from Greensboro, North Carolina, is pursuing an MD at Stanford School of Medicine as a Knight-Hennessy Scholar. He graduated cum laude from Harvard University with a bachelor’s degree in chemistry and a minor in psychology. Johnny aspires to lead medical practice in underserved communities and drive structural change to make health care more accessible at scale. While at Harvard, he led youth mentorship programming in Boston and Japan, conducted research in the natural and social sciences, and shadowed hospital physicians in Spain. As president of the Harvard Black Men’s Forum, Johnny implemented lasting infrastructure to promote public service and inclusion. After graduating, he worked as an associate consultant at Bain & Company on health care and social impact projects. Passionate about health equity, Johnny also served as research coordinator for the All of Us Research Program, a national National Institutes of Health initiative to increase diversity in health care research, at the University of Chicago.
-
Jessica Pullen
MD Student with Scholarly Concentration in Biomedical Ethics & Medical Humanities
Current Research and Scholarly InterestsIn collaboration with Dr. Meera Sankar, Medical Director of LPCH NICU and President-Elect of the California Association of Neonatologists, we are exploring the implications of implementing Transcutaneous versus serum measurements of Bilirubin for diagnosis and management of Hyperbilirubinemia. We are particularly interested in patient care benefits, cost/benefit analyses as well as implications for global health settings.
